Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan

Podobne knjige/članki

• Elevation of B‐Type Natriuretic Peptide at Discharge is Associated With 2‐Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN‐TAVI (Optimized Transcatheter Valvular Intervention–Transcatheter Aortic Valve Implantation) Registry
  od: Mizutani, Kazuki, et al.
  Izdano: (2017)
• Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry
  od: Saito, Tetsuya, et al.
  Izdano: (2020)
• Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry
  od: Enta, Yusuke, et al.
  Izdano: (2020)
• Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
  od: Miyasaka, Masaki, et al.
  Izdano: (2021)
• Identification of Anemia for Predicting Mid-Term Prognosis After Transcatheter Aortic Valve Implantation in Japanese Patients　― Insights From the OCEAN-TAVI Registry ―
  od: Onoda, Hiroshi, et al.
  Izdano: (2021)